202 related articles for article (PubMed ID: 25008344)
21. Two major grapefruit juice components differ in intestinal CYP3A4 inhibition kinetic and binding properties.
Paine MF; Criss AB; Watkins PB
Drug Metab Dispos; 2004 Oct; 32(10):1146-53. PubMed ID: 15269184
[TBL] [Abstract][Full Text] [Related]
22. Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of salvianolic acid A.
Han DE; Zheng Y; Chen X; He J; Zhao D; Yang S; Zhang C; Yang Z
Drug Metab Pharmacokinet; 2012; 27(6):579-85. PubMed ID: 22572482
[TBL] [Abstract][Full Text] [Related]
23. Enhanced bioactivity of silybin B methylation products.
Sy-Cordero AA; Graf TN; Runyon SP; Wani MC; Kroll DJ; Agarwal R; Brantley SJ; Paine MF; Polyak SJ; Oberlies NH
Bioorg Med Chem; 2013 Feb; 21(3):742-7. PubMed ID: 23260576
[TBL] [Abstract][Full Text] [Related]
24. A broad-spectrum substrate for the human UDP-glucuronosyltransferases and its use for investigating glucuronidation inhibitors.
Zhou QH; Qin WW; Finel M; He QQ; Tu DZ; Wang CR; Ge GB
Int J Biol Macromol; 2021 Jun; 180():252-261. PubMed ID: 33741369
[TBL] [Abstract][Full Text] [Related]
25. Strong inhibition of celastrol towards UDP-glucuronosyl transferase (UGT) 1A6 and 2B7 indicating potential risk of UGT-based herb-drug interaction.
Zhang YS; Tu YY; Gao XC; Yuan J; Li G; Wang L; Deng JP; Wang Q; Ma RM
Molecules; 2012 Jun; 17(6):6832-9. PubMed ID: 22669039
[TBL] [Abstract][Full Text] [Related]
26. Disposition of flavonoids via enteric recycling: UDP-glucuronosyltransferase (UGT) 1As deficiency in Gunn rats is compensated by increases in UGT2Bs activities.
Wang SW; Kulkarni KH; Tang L; Wang JR; Yin T; Daidoji T; Yokota H; Hu M
J Pharmacol Exp Ther; 2009 Jun; 329(3):1023-31. PubMed ID: 19264971
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Inhibition of Human UDP-Glucuronosyl-Transferase (UGT) Isoforms by Astaxanthin, β-Cryptoxanthin, Canthaxanthin, Lutein, and Zeaxanthin: Prediction of in Vivo Dietary Supplement-Drug Interactions.
Zheng YF; Min JS; Kim D; Park JB; Choi SW; Lee ES; Na K; Bae SK
Molecules; 2016 Aug; 21(8):. PubMed ID: 27529203
[TBL] [Abstract][Full Text] [Related]
28. Isolation and identification of intestinal CYP3A inhibitors from cranberry (Vaccinium macrocarpon) using human intestinal microsomes.
Kim E; Sy-Cordero A; Graf TN; Brantley SJ; Paine MF; Oberlies NH
Planta Med; 2011 Feb; 77(3):265-70. PubMed ID: 20717876
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory Effect of Hesperetin and Naringenin on Human UDP-Glucuronosyltransferase Enzymes: Implications for Herb-Drug Interactions.
Liu D; Wu J; Xie H; Liu M; Takau I; Zhang H; Xiong Y; Xia C
Biol Pharm Bull; 2016; 39(12):2052-2059. PubMed ID: 27904048
[TBL] [Abstract][Full Text] [Related]
30. In vitro selective inhibition of human UDP-glucuronosyltransferase (UGT) 1A4 by finasteride, and prediction of in vivo drug-drug interactions.
Lee SJ; Park JB; Kim D; Bae SH; Chin YW; Oh E; Bae SK
Toxicol Lett; 2015 Jan; 232(2):458-65. PubMed ID: 25448279
[TBL] [Abstract][Full Text] [Related]
31. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.
Sridar C; Goosen TC; Kent UM; Williams JA; Hollenberg PF
Drug Metab Dispos; 2004 Jun; 32(6):587-94. PubMed ID: 15155549
[TBL] [Abstract][Full Text] [Related]
32. Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements.
Loretz C; Ho MD; Alam N; Mitchell W; Li AP
Drug Metab Dispos; 2020 Oct; 48(10):1084-1091. PubMed ID: 32719085
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human aldehyde oxidase activity by diet-derived constituents: structural influence, enzyme-ligand interactions, and clinical relevance.
Barr JT; Jones JP; Oberlies NH; Paine MF
Drug Metab Dispos; 2015 Jan; 43(1):34-41. PubMed ID: 25326286
[TBL] [Abstract][Full Text] [Related]
34. Gossypol exhibits a strong influence towards UDP-glucuronosyltransferase (UGT) 1A1, 1A9 and 2B7-mediated metabolism of xenobiotics and endogenous substances.
Zhang YS; Yuan J; Fang ZZ; Tu YY; Hu CM; Li G; Wang L; Deng JP; Yao JJ; Li HR
Molecules; 2012 Apr; 17(5):4896-903. PubMed ID: 22543504
[TBL] [Abstract][Full Text] [Related]
35. Investigation of UDP-glucuronosyltransferases (UGTs) inhibitory properties of carvacrol.
Dong RH; Fang ZZ; Zhu LL; Liang SC; Ge GB; Yang L; Liu ZY
Phytother Res; 2012 Jan; 26(1):86-90. PubMed ID: 21544887
[TBL] [Abstract][Full Text] [Related]
36. Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7.
Fang ZZ; Wang H; Cao YF; Sun DX; Wang LX; Hong M; Huang T; Chen JX; Zeng J
Chirality; 2015 Mar; 27(3):189-93. PubMed ID: 25502512
[TBL] [Abstract][Full Text] [Related]
37. A fluorescence-based microplate assay for high-throughput screening and evaluation of human UGT inhibitors.
Zhou QH; Lv X; Tian ZH; Finel M; Feng L; Huo PC; Zhu YD; Lu Y; Hou J; Ge GB
Anal Chim Acta; 2021 Apr; 1153():338305. PubMed ID: 33714444
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions.
Pattanawongsa A; Chau N; Rowland A; Miners JO
Drug Metab Dispos; 2015 Oct; 43(10):1468-76. PubMed ID: 26180128
[TBL] [Abstract][Full Text] [Related]
39. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin.
Sadeque AJ; Usmani KA; Palamar S; Cerny MA; Chen WG
Drug Metab Dispos; 2012 Apr; 40(4):772-8. PubMed ID: 22259019
[TBL] [Abstract][Full Text] [Related]
40. Use of generally recognized as safe or dietary compounds to inhibit buprenorphine metabolism: potential to improve buprenorphine oral bioavailability.
Maharao N; Venitz J; Gerk PM
Biopharm Drug Dispos; 2019 Jan; 40(1):18-31. PubMed ID: 30520057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
